RNA — AVIDITY BIOSCIENCES INC

Ownership history in Bellevue Group AG  ·  2 quarters on record

This page tracks every 13F SEC filing in which Bellevue Group AG reported a position in AVIDITY BIOSCIENCES INC (RNA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
3.6% (2025 Q4)
Avg. % of fund
2.77%
First filed
2025 Q3
Last filed
2025 Q4
Quarters held
2
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 2,630,969 +478,107 +22.2% 3.60% $189.8M —
2025 Q3 INITIATED 2,152,862 — — 1.95% $93.8M —
% of Fund (quarterly)    RNA price (monthly, adj. close)

Other funds also holding RNA

As of 2025 Q4 — sorted by position size

ALETHEA CAPITAL MANAGEMENT, LLC 3Y 7Y 15.62% Slotnik Capital, LLC 12.01% Twin Securities, Inc. 3Y 7Y 10.07% Sand Grove Capital Management LLP 3Y 7Y 8.11% HARVEST MANAGEMENT LLC 3Y 7Y 7.61% Slotnik Capital, LLC 6.72% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 6.39% TIG Advisors, LLC 3Y 7Y 6.02% KRYGER CAPITAL Ltd 3Y 5.82% PSquared Asset Management AG 3Y 7Y 5.68%
← Back to Bellevue Group AG Holdings